Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
12.86
-0.27 (-2.06%)
At close: Aug 24, 2026, 4:00 PM EDT
13.24
+0.38 (2.95%)
Pre-market: Aug 25, 2026, 8:24 AM EDT

Candel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9843103694352224
Market Cap Growth
201.27%-15.87%767.25%-17.80%-76.95%-
Enterprise Value
83223036822-3137
Last Close Price
12.865.658.681.471.797.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----413.761794.84
PB Ratio
7.765.975.563.341.083.50
P/TBV Ratio
7.805.975.563.341.083.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----1092.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.940.201.790.480.01
Net Debt / Equity Ratio
-1.20-1.36-1.34-0.99-0.99-1.28
Net Debt / EBITDA Ratio
2.131.492.760.341.393.22
Net Debt / FCF Ratio
2.651.823.300.371.443.41
Asset Turnover
----0.000.00
Quick Ratio
15.8913.312.742.5012.4815.41
Current Ratio
16.0913.492.772.5912.8115.84
Return on Equity (ROE)
-81.84%-64.58%-139.56%-125.50%-33.61%-80.60%
Return on Assets (ROA)
-28.64%-25.95%-28.14%-39.95%-26.01%-25.22%
Return on Capital Employed (ROCE)
-36.80%-41.50%-48.10%-140.70%-48.20%-30.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.00%-12.31%-14.97%-89.24%-36.34%-16.10%
FCF Yield
-5.83%-12.54%-7.33%-81.63%-63.26%-10.72%
Buyback Yield / Dilution
-45.29%-67.19%-9.47%-0.39%-52.72%-62.49%
SEC Filings: 10-K · 10-Q